People

Sarah B. Noonberg

Neurogene board director and physician-scientist with experience in clinical drug development. Neurogene's current biography identifies her AbCellera chief medical officer appointment in September 2025, following earlier medical leadership at Metagenomi, Maze, Prothena and BioMarin. Holds UCSF medical, Berkeley bioengineering PhD and Dartmouth engineering degrees.

Roles

Neurogene

Board Member

Current